Simon H Stertzer - Insider Trading Tracker

BioCardia, Inc.

US ˙ NasdaqCM ˙ US09060U5074

Introduction

This page provides a comprehensive analysis of the known insider trading history of Simon H Stertzer. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

See Highest Ranking Insiders

Companies with Reported Insider Positions

The SEC filings indicate Simon H Stertzer has reported holdings or trades in the following companies:

Security	Title	Latest Reported Holdings
US:BCDA / BioCardia, Inc.	Director	192,654

How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Simon H Stertzer. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases BCDA / BioCardia, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in BCDA / BioCardia, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date	Ticker	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Max	Price at Max	Max Profit ($)	Max Return (%)
2025-06-30	BCDA	STERTZER SIMON H	72,289	2.0750	72,289	2.0750	150,000	10	2.4200	24,940	16.63
2025-04-23	BCDA	STERTZER SIMON H	104,986	1.9050	104,986	1.9050	199,998
2025-03-05	BCDA	STERTZER SIMON H	1,000	2.4500	1,000	2.4500	2,450
2025-03-04	BCDA	STERTZER SIMON H	15,536	2.3000	15,536	2.3000	35,733
2025-03-03	BCDA	STERTZER SIMON H	22,753	2.3000	22,753	2.3000	52,332
2020-06-19	BCDA;BCDAW	STERTZER SIMON H	142,850	2.1000	9,523	31.5000	299,985
2019-08-02	BCDA	STERTZER SIMON H	166,666	6.0000	11,111	90.0000	999,996
2019-08-02	BCDA;BCDAW	STERTZER SIMON H	41,667	6.0000	2,778	90.0000	250,002
2018-12-24	BCDA	STERTZER SIMON H	1,666,666	0.7500	138,889	9.0000	1,250,000
2018-12-24	BCDA	STERTZER SIMON H	1,666,666	0.7500	138,889	9.0000	1,250,000
2018-12-24	BCDA	STERTZER SIMON H	1,666,666	0.7500	138,889	9.0000	1,250,000
2018-11-29	BCDA	STERTZER SIMON H	1,000	2.1020	83	25.2240	2,102
2018-11-14	BCDA	STERTZER SIMON H	1,000	2.1405	83	25.6860	2,140
2018-11-13	BCDA	STERTZER SIMON H	1,000	2.1000	83	25.2000	2,100
2018-11-02	BCDA	STERTZER SIMON H	2,000	2.5300	167	30.3600	5,060
2018-10-11	BCDA	STERTZER SIMON H	1,000	2.7000	83	32.4000	2,700
2018-09-21	BCDA	STERTZER SIMON H	1,000	2.4300	83	29.1600	2,430
2018-09-18	BCDA	STERTZER SIMON H	5,000	1.5000	417	18.0000	7,500
2018-03-26	BCDA	STERTZER SIMON H	8,000	1.8700	667	22.4400	14,960
2018-03-23	BCDA	STERTZER SIMON H	10,000	1.9000	833	22.8000	19,000
2018-03-22	BCDA	STERTZER SIMON H	3,000	1.8700	250	22.4400	5,610
2018-03-21	BCDA	STERTZER SIMON H	4,000	1.9100	333	22.9200	7,640
2017-03-01	BCDA	STERTZER SIMON H	100,000	0.6415	8,333	7.6980	64,150
2017-01-09	BCDA	STERTZER SIMON H	10,000	0.8228	833	9.8736	8,228
2016-12-22	BCDA	STERTZER SIMON H	72,600	0.5100	6,050	6.1200	37,026
2016-11-01	BCDA	STERTZER SIMON H	100,000	0.1641	8,333	1.9692	16,410

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Sales BCDA / BioCardia, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in BCDA / BioCardia, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date	Ticker	Insider	Reported Shares	Reported Price	Adjusted Shares	Adjusted Price	Cost Basis	Days to Min	Price at Min	Max Loss Avoided ($)	Max Loss Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

Insider Trading History

This table shows the complete list of insider trades made by Simon H Stertzer as disclosed to the Securities Exchange Commission (SEC).

File Date	Tran Date	Form	Ticker	Security	Code	Shares	Remaining Shares	Percent Change	Share Price	Tran Value	Remaining Value
2025-07-02	2025-06-30	4	BCDA	BioCardia, Inc. Common Stock	P - Purchase	72,289	192,654	60.06	2.08	150,000	399,757
2025-04-25	2025-04-23	4	BCDA	BioCardia, Inc. Common Stock	P - Purchase	104,986	120,365	682.66	1.90	199,998	229,295
2025-03-07	2025-03-05	4	BCDA	BioCardia, Inc. Common Stock	P - Purchase	1,000	57,138	1.78	2.45	2,450	139,988
2025-03-05	2025-03-04	4	BCDA	BioCardia, Inc. Common Stock	P - Purchase	15,536	56,138	38.26	2.30	35,733	129,117
2025-03-05	2025-03-03	4	BCDA	BioCardia, Inc. Common Stock	P - Purchase	22,753	40,602	127.47	2.30	52,332	93,385
2023-06-26	2023-06-23	4	BCDA;BCDAW	BioCardia, Inc. Common Stock	A - Award	64,212	267,766	31.55	2.34	149,999	625,501
2022-12-19	2022-12-16	4	BCDA;BCDAW	BioCardia, Inc. Common Stock	A - Award	178,571	888,084	25.17	1.68	299,999	1,491,981
2021-06-15	2021-06-15	4	BCDA;BCDAW	BioCardia, Inc. Stock Option (right to buy)	A - Award	12,434	22,642	121.81
2021-04-07	2021-03-31	4	BCDA;BCDAW	BioCardia, Inc. Common Stock	A - Award	2,304	203,554	1.14
2021-01-05	2020-12-31	4	BCDA;BCDAW	BioCardia, Inc. Common Stock	A - Award	2,968	201,250	1.50
2021-01-05	2020-12-31	4	BCDA;BCDAW	BioCardia, Inc. Common Stock	A - Award	2,800	198,282	1.43
2020-10-09	2020-09-30	4	BCDA;BCDAW	BioCardia, Inc. Common Stock	A - Award	2,968	195,482	1.54
2020-07-01	2020-06-30	4	BCDA;BCDAW	BioCardia, Inc. Common Stock	A - Award	4,531	192,514	2.41
2020-06-23	2020-06-19	4	BCDA;BCDAW	BioCardia, Inc. Common Stock	P - Purchase	142,850	187,983	316.51	2.10	299,985	394,764
2020-05-20	2020-05-08	4	BCDA;BCDAW	BioCardia, Inc. Common Stock	A - Award	8,800	45,133	24.22
2020-05-20	2019-08-02	4/A	BCDA;BCDAW	BioCardia, Inc. Warrant (right to buy)	P - Purchase	41,667	41,667
2020-05-20	2019-08-02	4/A	BCDA;BCDAW	BioCardia, Inc. Common Stock	P - Purchase	41,667	91,544	83.54	6.00	250,002	549,264
2020-05-04	2020-04-30	4	BCDA;BCDAW	BioCardia, Inc. Common Stock	A - Award	4,531	32,739	16.06
2020-05-04	2020-04-30	4	BCDA;BCDAW	BioCardia, Inc. Common Stock	A - Award	26,875	28,208	2,016.13
2019-08-23	2019-07-26	4	BCDA;BCDAW	BioCardia, Inc. Restricted Stock Units	M - Exercise	-3,594	0	-100.00
2019-08-23	2019-07-26	4	BCDA;BCDAW	BioCardia, Inc. Common Stock	M - Exercise	3,594	3,594
2019-08-06	2019-08-06	4	BCDA	BioCardia, Inc. Warrant (right to buy)	P - Purchase	67,484	234,150	40.49
2019-08-06	2019-08-06	4	BCDA	BioCardia, Inc. Convertible promissory note	C - Conversion		0
2019-08-06	2019-08-06	4	BCDA	BioCardia, Inc. Common Stock	C - Conversion	67,484	709,513	10.51	3.00	202,452	2,128,539
2019-08-06	2019-08-02	4	BCDA	BioCardia, Inc. Warrant (right to buy)	P - Purchase	166,666	166,666
2019-08-06	2019-08-02	4	BCDA	BioCardia, Inc. Common Stock	P - Purchase	166,666	642,029	35.06	6.00	999,996	3,852,174
2019-08-06	2019-07-05	4	BCDA	BioCardia, Inc. Convertible promissory note	P - Purchase				200,000.00
2019-01-03	2018-12-24	4/A	BCDA	BioCardia, Inc. Warrant (right to buy)	P - Purchase	833,333	833,333
2019-01-03	2018-12-24	4/A	BCDA	BioCardia, Inc. Warrant (right to buy)	P - Purchase	833,333	833,333
2019-01-03	2018-12-24	4/A	BCDA	BioCardia, Inc. Common Stock	P - Purchase	1,666,666	2,076,346	406.82	0.75	1,250,000	1,557,260
2019-01-03	2018-12-24	4/A	BCDA	BioCardia, Inc. Common Stock	P - Purchase	1,666,666	4,278,274	63.82	0.75	1,250,000	3,208,706
2018-12-27	2018-12-24	4	BCDA	BioCardia, Inc. Warrant (right to buy)	P - Purchase	833,333	833,333
2018-12-27	2018-12-24	4	BCDA	BioCardia, Inc. Warrant (right to buy)	P - Purchase	833,333	833,333
2018-12-27	2018-12-24	4	BCDA	BioCardia, Inc. Common Stock	P - Purchase	1,666,666	2,076,346	406.82	0.75	1,250,000	1,557,260
2018-12-27	2018-12-24	4	BCDA	BioCardia, Inc. Common stock	P - Purchase	1,666,666	2,076,346	406.82	0.75	1,250,000	1,557,260
2018-12-27	2018-12-24	4/A	BCDA	BioCardia, Inc. Warrant (right to buy)	P - Purchase	833,333	833,333
2018-12-27	2018-12-24	4/A	BCDA	BioCardia, Inc. Warrant (right to buy)	P - Purchase	833,333	833,333
2018-12-27	2018-12-24	4/A	BCDA	BioCardia, Inc. Common stock	P - Purchase	1,666,666	2,076,346	406.82	0.75	1,250,000	1,557,260
2018-12-27	2018-12-24	4/A	BCDA	BioCardia, Inc. Common Stock	P - Purchase	1,666,666	4,283,275	63.70	0.75	1,250,000	3,212,456
2018-12-03	2018-11-29	4	BCDA	BioCardia, Inc. Common Stock	P - Purchase	1,000	6,000	20.00	2.10	2,102	12,612
2018-11-16	2018-11-14	4	BCDA	BioCardia, Inc. Common Stock	P - Purchase	1,000	5,000	25.00	2.14	2,140	10,702
2018-11-13	2018-11-13	4	BCDA	BioCardia, Inc. Common Stock	P - Purchase	1,000	4,000	33.33	2.10	2,100	8,400
2018-11-06	2018-11-02	4	BCDA	BioCardia, Inc. Common Stock	P - Purchase	2,000	3,000	200.00	2.53	5,060	7,590
2018-10-12	2018-10-11	4	BCDA	BioCardia, Inc. Common Stock	P - Purchase	1,000	1,000		2.70	2,700	2,700
2018-09-26	2018-07-26	4	BCDA	BioCardia, Inc. Restricted Stock Units	A - Award	32,353	32,353
2018-09-26	2018-09-18	4/A	BCDA	BioCardia, Inc. Common Stock	P - Purchase	5,000	2,616,609	0.19	1.50	7,500	3,924,914
2018-09-24	2018-09-21	4	BCDA	BioCardia, Inc. Common Stock	P - Purchase	1,000	2,609,609	0.04	2.43	2,430	6,341,350
2018-09-20	2018-09-18	4	BCDA	BioCardia, Inc. Common Stock	P - Purchase	5,000	2,608,609	0.19	1.50	7,500	3,912,914
2018-03-26	2018-03-26	4	BCDA	BioCardia, Inc. Common Stock	P - Purchase	8,000	2,611,609	0.31	1.87	14,960	4,883,709
2018-03-26	2018-03-23	4	BCDA	BioCardia, Inc. Common Stock	P - Purchase	10,000	2,603,609	0.39	1.90	19,000	4,946,857
2018-03-22	2018-03-22	4	BCDA	BioCardia, Inc. Common Stock	P - Purchase	3,000	2,593,608	0.12	1.87	5,610	4,850,047
2018-03-22	2018-03-21	4	BCDA	BioCardia, Inc. Common Stock	P - Purchase	4,000	2,590,608	0.15	1.91	7,640	4,948,061
2017-08-25	2017-06-15	4	BCDA	BioCardia, Inc. Director Stock Option (right to buy)	A - Award	156,583	156,583
2017-03-02	2017-03-01	4	BCDA	BioCardia, Inc. Common Stock	P - Purchase	100,000	4,916,171	2.08	0.64	64,150	3,153,724
2017-01-18	2017-01-13	4	BCDA	BioCardia, Inc. Director Stock Option (right to buy)	A - Award	267,000	267,000
2017-01-10	2017-01-09	4	BCDA	BioCardia, Inc. Common Stock	P - Purchase	10,000	31,039,310	0.03	0.82	8,228	25,539,144
2016-12-27	2016-12-22	4	BCDA	BioCardia, Inc. Common Stock	P - Purchase	72,600	31,029,310	0.23	0.51	37,026	15,824,948
2016-12-27	2016-11-01	4	BCDA	BioCardia, Inc. Common Stock	P - Purchase	100,000	4,816,171	2.12	0.16	16,410	790,334
2016-10-26		3	BCDA	BioCardia, Inc. Common Stock			73,275,259
2016-10-26		3	BCDA	BioCardia, Inc. Common Stock			43,577,474
2016-10-26		3	BCDA	BioCardia, Inc. Common Stock			47,705,292
2016-10-26		3	BCDA	BioCardia, Inc. Common Stock			47,034,720
2016-10-26		3	BCDA	BioCardia, Inc. Common Stock			73,275,259
2016-10-26		3	BCDA	BioCardia, Inc. Common Stock			43,577,474
2016-10-26		3	BCDA	BioCardia, Inc. Common Stock			47,705,292
2016-10-26		3	BCDA	BioCardia, Inc. Common Stock			47,034,720

Open market or private purchase of non-derivative or derivative security

Open market or private sale of non-derivative or derivative security

Grant, award, or other acquisition of securities from the company (such as an option)

Conversion of derivative

Sale or transfer of securities back to the company

Payment of exercise price or tax liability using portion of securities received from the company

Gift of securities by or to the insider

Equity swaps and similar hedging transactions

Exercise or conversion of derivative security received from the company (such as an option)

A transaction voluntarily reported on Form 4

Other (accompanied by a footnote describing the transaction)